Characteristic | All | Boys | Girls | Pvalue |
---|---|---|---|---|
Group 2 to 6 years | n = 994 | n = 524 | n = 470 | |
Age, years | 4.4 ± 0.8 | 4.5 ± 0.8 | 4.4 ± 0.8 | 0.226 |
Body mass, kg | 18.3 ± 3.5 | 18.5 ± 3.5 | 18.0 ± 3.4 | 0.011 |
Height, cm | 107.2 ± 7.4 | 107.8 ± 7.4 | 106.6 ± 7.5 | 0.011 |
BMI, kg/m2a | 15.8 ± 1.7 | 15.9 ± 1.6 | 15.7 ± 1.8 | 0.170 |
Sum of two skinfolds, mma | 16.5 ± 5.0 | 15.3 ±54.3 | 17.7 ± 5.3 | <0.001b |
DBP, mmHg | 62.1 ± 6.2 | 62.0 ± 6.1 | 62.2 ± 6.3 | 0.617 |
SBP, mmHg | 97.4 ± 8.4 | 97.7 ± 8.5 | 97.1 ± 8.2 | 0.238 |
Glucose, mmol/l | 4.51 ± 0.51 | 4.55 ± 0.54 | 4.46 ± 0.48 | 0.010 |
Insulin, pmol/la | 22.64 ± 18.47 | 21.39 ± 17.36 | 24.10 ± 19.52 | 0.011 |
HOMA-IRa | 0.68 ± 0.62 | 0.65 ± 0.57 | 0.72 ± 0.66 | 0.011 |
Cholesterol, mmol/l | 4.02 ± 0.73 | 3.99 ± 0.72 | 4.06 ± 0.74 | 0.127 |
HDL-c, mmol/l | 1.23 ± 0.34 | 1.29 ± 0.33 | 1.19 ± 0.35 | 0.001b |
Triglycerides, mmol/l | 0.46 ± 0.25 | 0.45 ± 0.23 | 0.48 ± 0.28 | 0.188 |
Light PA, min/daya | 395 ± 65 | 400 ± 65 | 390 ± 66 | 0.019 |
Moderate PA, min/daya | 31 ± 16 | 34 ± 17 | 27 ± 14 | <0.001b |
Vigorous PA, min/daya | 5 ± 5 | 6 ± 6 | 5 ± 5 | 0.281 |
MVPA, min/daya | 36 ± 20 | 39 ± 21 | 32 ± 17 | <0.001b |
Total PA, cpm | 598 ± 174 | 627 ± 179 | 565 ± 162 | <0.001b |
CVD risk score CRFs | 0.02 ± 2.74 | 0.01 ± 2.70 | 0.03 ± 2.77 | 0.879 |
Group 6 to 9 years | n = 2,025 | n = 1,038 | n = 987 | |
Age, years | 7.6 ± 0.8 | 7.6 ± 0.8 | 7.6 ± 0.8 | 0.926 |
Body mass, kg | 27.7 ± 6.7 | 28.0 ± 6.9 | 27.5 ± 6.3 | 0.088 |
Height, cm | 127.5 ± 7.3 | 128.2 ± 7.4 | 126.9 ± 7.3 | <0.001b |
BMI, kg/m2a | 16.9 ± 2.9 | 16.9 ± 3.0 | 16.9 ± 2.8 | 0.618 |
Sum of two skinfolds, mma | 19.8 ± 9.5 | 18.3 ± 9.2 | 21.4 ± 9.2 | 0.070 |
DBP, mmHg | 64.2 ± 6.5 | 64.0 ± 6.7 | 64.5 ± 6.3 | 0.018 |
SBP, mmHg | 103.2 ± 8.7 | 103.7 ± 8.7 | 102.8 ± 8.6 | 0.070 |
Glucose: mmol/l | 4.81 ± 0.52 | 4.88 ± 0.52 | 4.75 ± 0.49 | <0.001b |
Insulin, pmol/la | 35.84 ± 24.65 | 33.41 ± 22.43 | 38.34 ± 24.93 | <0.001b |
HOMA-IRa | 1.13 ± 0.83 | 1.07 ± 0.77 | 1.20 ± 0.84 | <0.001b |
Cholesterol, mmol/l | 4.19 ± 0.83 | 4.11 ± 0.77 | 4.28 ± 0.84 | <0.001b |
HDL-c, mmol/l | 1.40 ± 0.38 | 1.42 ± 0.39 | 1.38 ± 0.37 | 0.016 |
Triglycerides, mmol/l | 0.47 ± 0.26 | 0.45 ± 0.24 | 0.49 ± 0.29 | <0.001b |
Light PA, min/daya | 364 ± 64 | 364 ± 63 | 364 ± 17 | 0.940 |
Moderate PA, min/daya | 35 ± 17 | 41 ± 19 | 30 ± 12 | <0.001b |
Vigorous PA, min/daya | 8 ± 6 | 8 ± 6 | 7 ± 8 | 0.001b |
MVPA, min/daya | 43 ± 22 | 49 ± 23 | 37 ± 18 | <0.001b |
Total PA, cpm | 581 ± 169 | 609 ± 175 | 553 ± 157 | <0.001b |
Cardiorespiratory fitness, ml/kg/minc | 41.7 ± 14.5 | 42.2 ± 14.3 | 41.3 ± 13.8 | 0.01 |
Stages (total number) | 1.9 ± 1.3 | 2.1 ± 1.5 | 1.7 ± 1.1 | <0.001b |
CVD risk score CRFs | 0.13 ± 3.11 | 0.09 ± 3.03 | 0.18 ± 3.19 | 0.501 |
CVD risk score CRFs + fitc | −0.28 ± 3.26 | −0.26 ± 3.016 | −0.31 ± 3.36 | 0.775 |